Tan, 285 patient HCQ late treatment study: 35% shorter hospitalization [p=0.04] https://c19p.org/tan2
copied to clipboard
A retrospective comparison of drugs against COVID-19
et al., Virus Research, doi:10.1016/j.virusres.2020.198262
Retrospective 333 patients in China, with only 8 HCQ patients, showing shorter duration of hospitalization with HCQ.
|
hospitalization time, 35.2% lower, relative time 0.65, p = 0.04, treatment 8, control 277.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Tan et al., 12/14/2020, retrospective, China, Asia, peer-reviewed, 7 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.